Lumither Dry Syrup

Lumither Dry Syrup is a highly effective antimalarial combination therapy formulated especially for pediatric use. This child-friendly oral suspension is indicated for the treatment of uncomplicated malaria caused by Plasmodium falciparum, including strains that are resistant to chloroquine and other antimalarial drugs.

This medicine contains two powerful antimalarial agents:

• Artemether (40 mg): A fast-acting derivative of artemisinin, which quickly reduces parasite load.

• Lumefantrine (240 mg): A longer-acting compound that works synergistically with artemether to ensure complete parasite elimination and prevent recurrence.

This oral suspension is ideal for infants and young children, or adults who are unable to swallow tablets. Its pleasant taste and liquid form make dosing easier and more accurate, especially in pediatric patients.

Approved by leading health organizations, this Artemether + Lumefantrine suspension is part of the Artemisinin-based Combination Therapy (ACT) regimen recommended by the World Health Organization (WHO). It is widely used across malaria-endemic regions, including Africa, Asia, and South America.